Download up to 50 records using a credit card to purchase your current search results.
Purchase your current search resultsIf your search contains more than 50 records, you will receive only the first 50 based on the sorting chosen at the time of purchase. Downloads will contain all fields shown in the individual records, not only those visible on the search results page. If your search is 50 records or higher, a subscription might be a better option.
If your search contains fewer than 50 records, the balance cannot be used for a separate search.
Once you subscribe, you will be able to download your current search results. Downloads will contain all fields shown in the individual records, not only those visible on the search results page.
If the number of records in your search results exceeds the limit of your subscription tier, your download will include the maximum number based on the sorting chosen at the time of the download.
Top 5 Jurisdictions | Penalty Total (USD) | Number of Records |
---|---|---|
United States | $10,334,722,171 | 59 |
France | $39,661,700 | 2 |
European Commission | $14,809,133 | 1 |
United Kingdom | $7,891,069 | 1 |
Italy | $4,423,130 | 1 |
Top 5 Offense Groups | Penalty Total (USD) | Number of Records |
---|---|---|
healthcare-related offenses | $8,465,500,000 | 15 |
consumer-protection-related offenses | $712,141,980 | 6 |
safety-related offenses | $622,717,201 | 18 |
government-contracting-related offenses | $464,555,368 | 9 |
competition-related offenses | $141,545,653 | 10 |
Click on the company or penalty amount for more information on each case.
Company | Current Parent Industry | Offense Category | Year | Jurisdiction | Penalty Amount (USD) |
---|---|---|---|---|---|
Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | United States | $5,000,000,000 |
Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | United States | $2,200,000,000 |
Johnson & Johnson | pharmaceuticals | consumer protection violation | 2024 | United States | $700,000,000 |
Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $541,000,000 |
Janssen Pharmaceuticals, Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | United States | $410,000,000 |
Actelion Pharmaceuticals US, Inc. | pharmaceuticals | government contracting fraud | 2018 | United States | $360,000,000 |
Johnson and Johnson | pharmaceuticals | drug or medical equipment safety violation | 2023 | United States | $302,000,000 |
Janssen Pharmaceuticals, Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | United States | $181,000,000 |
Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | United States | $158,000,000 |
Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | United States | $149,500,000 |
Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | United States | $120,000,000 |
Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | United States | $116,860,000 |
Janssen Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $99,000,000 |
Scios Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | United States | $85,000,000 |
Ortho-McNeil Pharmaceutical LLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | United States | $81,000,000 |
Johnson & Johnson | pharmaceuticals | government contracting fraud | 2019 | United States | $49,505,368 |
Johnson & Johnson | pharmaceuticals | kickbacks and bribery | 2011 | United States | $48,600,000 |
Janssen Pharmaceuticals/Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $40,500,000 |
Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $40,500,000 |
Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2017 | United States | $33,000,000 |
Janssen-Cilag | pharmaceuticals | anti-competitive practices | 2017 | France | $29,529,700 |
McNeil-PPC Inc. | pharmaceuticals | drug or medical equipment safety violation | 2015 | United States | $25,000,000 |
Ortho-McNeil Pharmaceutical LLC | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $24,681,516 |
Johnson & Johnson | pharmaceuticals | kickbacks and bribery | 2011 | United States | $21,400,000 |
Acclarent Inc. | pharmaceuticals | government contracting fraud | 2016 | United States | $18,000,000 |
Janssen Pharmaceuticals, Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | United States | $15,100,000 |
Johnson & Johnson | pharmaceuticals | anti-competitive practices | 2013 | European Commission | $14,809,133 |
Laboratoire Vendome | pharmaceuticals | anti-competitive practices | 2014 | France | $10,132,000 |
Johnson & Johnson | pharmaceuticals | government contracting fraud | 2013 | United States | $10,000,000 |
Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | United States | $9,900,000 |
Ethicon | pharmaceuticals | consumer protection violation | 2023 | United States | $9,900,000 |
DePuy Synthes, Inc. | pharmaceuticals | government contracting fraud | 2023 | United States | $9,750,000 |
DePuy International Limited | pharmaceuticals | kickbacks and bribery | 2011 | United Kingdom | $7,891,069 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | pharmaceuticals | government contracting fraud | 2012 | United States | $7,000,000 |
Ortho-McNeil Pharmaceutical LLC | pharmaceuticals | drug or medical equipment safety violation | 2010 | United States | $6,140,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | United States | $5,900,000 |
Johnson & Johnson et al. | pharmaceuticals | government contracting fraud | 2010 | United States | $5,200,000 |
Johnson & Johnson S.p.A. | pharmaceuticals | anti-competitive practices | 2010 | Italy | $4,423,130 |
DePuy Orthopaedics Inc. | pharmaceuticals | drug or medical equipment safety violation | 2014 | United States | $4,000,000 |
Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2020 | United States | $3,900,000 |
Abiomed, Inc. | pharmaceuticals | government contracting fraud | 2018 | United States | $3,100,000 |
Janssen Korea Ltd. | pharmaceuticals | anti-competitive practices | 2011 | South Korea | $2,396,932 |
Johnson & Johnson | pharmaceuticals | government contracting fraud | 2011 | United States | $2,000,000 |
Johnson & Johnson | pharmaceuticals | anti-competitive practices | 2014 | South Korea | $1,780,680 |
Advanced Sterilization Products, a division of Ethicon Inc. | pharmaceuticals | drug or medical equipment safety violation | 2013 | United States | $1,200,000 |
Johnson & Johnson Hellas | pharmaceuticals | consumer protection violation | 2023 | Greece | $1,085,980 |
Synthes Inc. | pharmaceuticals | drug or medical equipment safety violation | 2010 | United States | $669,800 |
Johnson & Johnson | pharmaceuticals | anti-competitive practices | 2014 | China | $583,009 |
Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | United States | $506,000 |
McNeil-PPC Inc. | pharmaceuticals | consumer protection violation | 2015 | United States | $500,000 |
Neutrogena Corp. | pharmaceuticals | environmental violation | 2014 | United States | $416,248 |
Johnson & Johnson, Inc. | pharmaceuticals | insurance violation | 2020 | United States | $150,000 |
Advanced Sterilization Products | pharmaceuticals | environmental violation | 2014 | United States | $136,800 |
Advanced Sterilization Products, Div of Ethicon | pharmaceuticals | environmental violation | 2014 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $136,800 |
Janssen Pharmaceutical (SB) | pharmaceuticals | environmental violation | 2010 | United States | $105,000 |
Depuy Synthes Sales, Inc. | pharmaceuticals | labor standards violation | 2020 | United States | $57,488 |
Abiomed Inc. | pharmaceuticals | employment discrimination | 2024 | United States | $57,000 |
DePuy Synthes | pharmaceuticals | environmental violation | 2019 | United States | $51,750 |
JANSSEN PHARMACEUTICALS, INC. | pharmaceuticals | environmental violation | 2024 | United States | $30,400 |
Advanced Sterilization Products | pharmaceuticals | pesticide violation | 2012 | United States | $25,616 |
ADVANCED STERILIZATION PRODUCTS INC | pharmaceuticals | environmental violation | 2023 | United States | $13,300 |
ETHICON, INC. | pharmaceuticals | workplace safety or health violation | 2020 | United States | $9,832 |
JOHNSON & JOHNSON CONSUMER, INC. | pharmaceuticals | workplace safety or health violation | 2018 | United States | $7,853 |
DEPUY SYNTHES PRODUCTS, INC. | pharmaceuticals | workplace safety or health violation | 2022 | United States | $7,044 |
ETHICON, INC. | pharmaceuticals | workplace safety or health violation | 2017 | United States | $6,518 |
DEPUY SYNTHES PRODUCTS, LLC | pharmaceuticals | workplace safety or health violation | 2018 | United States | $5,654 |
ETHICON ENDO SURGERY | pharmaceuticals | aviation safety violation | 2010 | United States | $5,500 |
DEPUY SYNTHES | pharmaceuticals | workplace safety or health violation | 2019 | United States | $5,000 |